Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736852 · ClinicalTrials.gov registry record · NA
Evaluation of CRB in PROM Patients
A NA study, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
NCT01736852 is a NA study that has completed, run by Cook Group Incorporated. The registered enrollment target is 129 participants.
The verdict
NCT01736852, a NA study, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
Study Summary
The CRB study is designed to study the safety and effectiveness of the Cook Cervical Ripening Balloon (CRB) for the induction of labor in term and near-term patients with premature rupture of membranes (PROM).
Interventions
- DRUG Pitocin
- DEVICE CRB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2012-11 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01736852
The ClinicalTrials.gov registry entry for NCT01736852 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pitocin is the first listed.
NCT01736852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01736852 about?
NCT01736852 is a clinical study titled "Evaluation of CRB in PROM Patients". The CRB study is designed to study the safety and effectiveness of the Cook Cervical Ripening Balloon (CRB) for the induction of labor in term and near-term patients with premature rupture of membranes (PROM).
What is the current status of trial NCT01736852?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2012-11. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT01736852?
The interventions under investigation include: Pitocin (DRUG), CRB (DEVICE).
Who is sponsoring clinical trial NCT01736852?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.